Employees: 03 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2002-06-02 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VALLAURIS (06220), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE DES ILES : revenue, balance sheet and financial ratios
SELAS PHARMACIE DES ILES is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VALLAURIS (06220),
this company of category PME
shows in 2024 a net income positive of 71 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE DES ILES (SIREN 448164210)
Indicator
2024
2023
2022
2021
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
70 674 €
46 720 €
162 112 €
82 815 €
89 112 €
90 336 €
71 162 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELAS PHARMACIE DES ILES generates positive net income of 71 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 71 k€ -> 71 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
70 674 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
40.404%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.437%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELAS PHARMACIE DES ILES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2021
2022
2023
2024
Debt ratio
161.984
136.963
115.899
60.572
49.6
43.678
40.404
Financial autonomy
34.271
37.842
41.526
56.048
59.936
62.921
65.437
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
40.42024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of SELAS PHARMACIE DES ILES (40.40) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
65.44%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of SELAS PHARMACIE DES ILES (65.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 191.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
191.74
Liquidity indicators evolution SELAS PHARMACIE DES ILES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2021
2022
2023
2024
Liquidity ratio
136.981
132.685
119.839
197.897
185.798
171.077
191.74
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
191.742024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good+9 pts over 3 years
In 2024, the liquidity ratio of SELAS PHARMACIE DES ILES (191.74) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE DES ILES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE DES ILES is estimated at
986 661 €
(range 687 095€ - 1 476 101€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
687k€986k€1476k€
986 661 €Range: 687 095€ - 1 476 101€
NAF 5 année 2024
Valuation method used
Net Income Multiple
70 674 €
×
14.0x
=986 661 €
Range: 687 095€ - 1 476 102€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE DES ILES with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE DES ILES
What is the revenue of SELAS PHARMACIE DES ILES ?
The revenue of SELAS PHARMACIE DES ILES is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE DES ILES profitable?
Yes, SELAS PHARMACIE DES ILES generated a net profit of 71 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE DES ILES ?
The headquarters of SELAS PHARMACIE DES ILES is located in VALLAURIS (06220), in the department Alpes-Maritimes.
Where to find the tax return of SELAS PHARMACIE DES ILES ?
The tax return of SELAS PHARMACIE DES ILES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE DES ILES operate?
SELAS PHARMACIE DES ILES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart